glycerophosphoinositol 4,5-bisphosphate and Muscle Weakness

glycerophosphoinositol 4,5-bisphosphate has been researched along with Muscle Weakness in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Behr, E; Bendahhou, S; Cobo, AM; Donaldson, MR; Escolar, DM; Fu, YH; Jensen, JL; Mozaffar, T; Pereira, S; Poza, JJ; Ptácek, LJ; Suarez, WA; Szepetowski, P; Tawil, R; Tristani-Firouzi, M; Wagstaff, J	1

Other Studies

1 other study(ies) available for glycerophosphoinositol 4,5-bisphosphate and Muscle Weakness

Article	Year
PIP2 binding residues of Kir2.1 are common targets of mutations causing Andersen syndrome. Neurology, 2003, Jun-10, Volume: 60, Issue:11 Topics: Abnormalities, Multiple; Arrhythmias, Cardiac; Binding Sites; Female; Genetic Predisposition to Disease; Humans; Male; Muscle Weakness; Mutation; Paralysis; Pedigree; Phenotype; Phosphatidylinositol 4,5-Diphosphate; Potassium Channels, Inwardly Rectifying; Syndrome	2003

Article

Year

PIP2 binding residues of Kir2.1 are common targets of mutations causing Andersen syndrome.

Neurology, 2003, Jun-10, Volume: 60, Issue:11

Topics: Abnormalities, Multiple; Arrhythmias, Cardiac; Binding Sites; Female; Genetic Predisposition to Disease; Humans; Male; Muscle Weakness; Mutation; Paralysis; Pedigree; Phenotype; Phosphatidylinositol 4,5-Diphosphate; Potassium Channels, Inwardly Rectifying; Syndrome

2003